Ztalmy 50 MG in 1 mL Oral Suspension

RxCUI: 2604700
RxNorm name: Ztalmy 50 MG in 1 mL Oral Suspension
Display name: Ztalmy 50 MG in 1 mL Oral Suspension
Full name: Ztalmy 50 MG in 1 mL Oral Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZTALMY	GANAXOLONE	Immedica Pharma US Inc	d91612c4-b03a-4be4-a1ee-6a13e3b83d4e	2025-11-28	Warnings, Adverse reactions	Exact identifier rxcui: 2604700

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d91612c4-b03a-4be4-a1ee-6a13e3b83d4e	Ztalmy 50 MG in 1 mL Oral Suspension	PSN	13	These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022	20251128
d91612c4-b03a-4be4-a1ee-6a13e3b83d4e	Ztalmy 50 MG/ML Oral Suspension	SY	13	These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022	20251128
d91612c4-b03a-4be4-a1ee-6a13e3b83d4e	ganaxolone 50 MG/ML Oral Suspension [Ztalmy]	SBD	13	These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022	20251128
d91612c4-b03a-4be4-a1ee-6a13e3b83d4e	Ztalmy 50 MG per 1 ML Oral Suspension	SY	13	These highlights do not include all the information needed to use ZTALMY ® safely and effectively. See full prescribing information for ZTALMY. ZTALMY ® (ganaxolone) oral suspension, CV Initial U.S. Approval: 2022	20251128